Anti-tumor Activities of Recombined Human RGD-FasL Against Three Glioma Cell Lines U138/U373/U343

Guohong Zhuang
2009-01-01
Abstract:Objective To study the cytotoxic effects of RGD-FasL on glioma cell lines U138/U373/U343 and the underlying mechanism. Methods Fas/DcR3 mRNA was detected by RT-PCR and its surface expression in the three cell lines was measured by flow cytometry analysis. Cytotoxicity exerted by RGD-FasL on glioma cell lines was measured with MTT assay and the induced apoptosis was determined by agarose gel electrophoresis. The cell cycle and apoptosis were assessed by flow cytometry with PI staining. The expressions of Caspase8/9/3 and Bcl-2 in cells were detected by Western blotting. Results Approximately 25.5 % of U138 cells,13.7% of U373 cells,and 13.9% of U343 cells expressed Fas,while about 22.2 % of U138 cells,15.5 % of U373 cells,and 23.4% of U343 cells expressed DcR3. The results were consistent with mRNA expressions of Fas and DcR3. Cell line U138 was sensitive to RGD-FasL in a dose-dependent manner; cell line U343 was partially sensitive to RGD-FasL; cell line U373 was sustained to RGD-FasL. The cell cycle analysis suggested that RGD-FasL could inhibit cells in G0/G1 phase and G2/M phase,thus inhibit cell growth. In U138 cells treated with RGD-FasL the AI was higher than that of FasL-treated cells,while in U343 cells the result was on the contrary. The expressions of Caspase-8/9/3,RANKL,JNK2 were increased after treating with RGD-FasL,while the expression of Bcl-2 was decreased obviously,suggesting RGD-FasL might pass the apoptosis signal through Caspase activation. Conclusion Recombined human RGD-FasL could induce apoptosis in glioma cell lines U138/U373/U343. The underlying mechanism may be relevant to the mRNA expressions of their receptors and the release of Caspase-8/9/3 and Bcl-2.
What problem does this paper attempt to address?